Active ingredient: Testosterone 10 mg/0.5 g actuation; metered-dose pump; topical gel. Indication: Primary hypogonadism. Hypogonadotropic hypogonadism. Pharmacology: Fortesta is a topical gel ...
HYDERABAD, India & PRINCETON, N.J.--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today ...
In the authors’ opinion and clinical experience, daily gel application can be disruptive to a patient’s routine. In theory, a higher concentration product should be more convenient because of lower ...
(Reuters) - U.S. drug regulators approved a new testosterone gel from BioSante Pharmaceutical Inc and Teva Pharmaceuticals, a Food and Drug Administration spokeswoman said. Bio-T-Gel is a topical, ...
San Francisco, Calif. and Torrance, Calif. (June 20, 2002) – A Phase 3 study conducted at multiple research centers in the U.S. under the direction of Ronald Swerdloff, MD, Principal Investigator at ...
The purpose of the present study was to evaluate the efficacy and safety of 50 mg/day of TTG, applied on non-scrotal skin, for hypogonadal men in Taiwan. Although TTG has been shown to be effective in ...